Today: 21 May 2026
Browse Category

NASDAQ:GLUE 16 December 2025

Biotech Stocks Today: FDA Fast Track Wins, PDUFA Delays and Deal Flow Move GLUE, ALDX, ADAG, PVLA as XBI and IBB Slide

Biotech Stocks Today: FDA Fast Track Wins, PDUFA Delays and Deal Flow Move GLUE, ALDX, ADAG, PVLA as XBI and IBB Slide

Biotech ETFs XBI and IBB each fell about 1.1% by early afternoon in New York, underperforming the broader market. Monte Rosa Therapeutics surged roughly 12% after reporting positive interim Phase 1/2 data for its prostate cancer drug candidate MRT-2359. The company plans a Phase 2 study in 2026. Broader biotech sentiment remained cautious despite sharp moves in select stocks.
16 December 2025
····

Stock Market Today

  • Ralph Lauren Q1 CY2026 Earnings Beat Estimates, Shares Surge
    May 21, 2026, 9:45 AM EDT. Ralph Lauren (NYSE:RL) reported Q1 CY2026 revenue of $1.98 billion, surpassing analyst estimates by 7%, with a 16.6% year-on-year increase. Adjusted earnings per share (EPS) stood at $2.80, beating forecasts by 10.1%. Operating margin remained stable at 9.5%, while free cash flow margin improved to 4.7% from 2.5% a year prior. Despite recent growth slowing to 10.6% annualized over two years compared to a five-year 13% CAGR, sales in constant currency rose 12.1%. Analysts anticipate a 4.1% revenue rise for the next 12 months, signalling a potential slowdown amid shifting consumer preferences in the discretionary sector. Market capitalization is $19.93 billion. Ralph Lauren's mixed outlook prompts caution despite strong initial results.

Latest articles

Stellantis Launches $70 Billion Overhaul With Focus on Jeep, Ram, China

Stellantis Launches $70 Billion Overhaul With Focus on Jeep, Ram, China

21 May 2026
Stellantis announced a €60 billion, five-year plan Thursday, focusing investment on Jeep, Ram, Peugeot, Fiat, and its commercial vehicles. Shares dropped over 5% in early European trading after the announcement. The company aims to launch over 60 new vehicles by 2030 and cut development cycles to 24 months. CEO Antonio Filosa is targeting 25% North American revenue growth and €6 billion in annual cost reductions.
Nike stock climbs but analysts hold back on turnaround calls

Nike stock climbs but analysts hold back on turnaround calls

21 May 2026
Nike shares climbed 3.4% to $44.07 Wednesday as falling oil prices and lower U.S. Treasury yields boosted consumer stocks. Nike reported flat quarterly revenue at $11.3 billion, with direct-to-consumer sales down 4% and net income down 35%. The company plans to launch a Google Gemini-powered shopping feature in June. Nike’s global footwear market share slipped to 22.9% in 2025, while Adidas gained, Reuters said.
Infleqtion shares react to $100 million quantum funding news in Washington

Infleqtion shares react to $100 million quantum funding news in Washington

21 May 2026
Infleqtion shares rose 5.1% premarket Thursday after the U.S. Commerce Department signed a preliminary $100 million funding letter for its neutral-atom quantum computing project, which would also give the government stock in the company. The proposed award, not yet final, is contingent on milestones and approvals. INFQ last traded at $11.18 before the New York open. D-Wave and Rigetti also saw premarket gains.
Go toTop